Ibex Medical Analytics and Medipath engage in a strategic partnership to unleash the power of Artificial Intelligence in Medipath’s pathology labs in France
Tel Aviv, Israel and Frejus, France, September 4, 2019 – Ibex Medical Analytics, a pioneer in Artificial Intelligence-based cancer diagnostics, and Medipath, the largest network of private pathology labs in France, announce today a partnership, designed to introduce artificial intelligence to the workflow in Medipath’s pathology labs and co-develop the next generation of Ibex’s product suite.
Ibex Medical Analytics provides an Artificial Intelligence (AI)-based decision support platform for pathology labs, empowering pathologists to deliver quick, objective and accurate diagnoses. The company recently raised $11 million toward the expansion of its offering and commercial footprint.
The engagement with Medipath follows collaborations in additional geographies, including a strategic partnership with Maccabi Healthcare Services, Israel’s second largest HMO, and a collaboration with UPMC (The University of Pittsburgh Medical Center) in the United States. It is another step toward global integration of Ibex’s AI-based tools for cancer diagnosis in pathology labs. Ibex Second ReadTM System for prostate cancer, the first-ever AI-driven diagnostics application in clinical use in a pathology lab, has already demonstrated significant clinical value by alerting pathologists to cancer cases.
Medipath and Ibex will present the initial outcomes from the partnership at the European Congress of Pathology, held next week in Nice, France, with an abstract titled ”Performance of an AI-based cancer diagnosis system in France’s largest network of pathology institutes”, presented on Tuesday, September 10th. Ibex will hold a booth at the congress (#A16).
“Medipath is the largest network of pathology labs in France. As part of our commitment and dedication to our patients and customers, we strive to utilize state-of-the-art technologies to produce quick and accurate results, providing unsurpassed levels of quality, reliability and efficiency. We strongly believe in the value proposition of artificial intelligence in healthcare and specifically in pathology, and are proud to partner with Ibex Medical Analytics, which is at the heart of the development and implementation of artificial intelligence for pathology labs and cancer diagnoses”, says Olivier Vire, Chairman, Medipath.
“We are excited to work with Medipath on introducing AI-based algorithms to their clinical workflow, enabling the Medipath network to retain its leadership position in the pathology market and to ensure the best quality of service for their patients and customers”, says Joseph Mossel, Ibex Medical Analytics CEO.
About Ibex Medical Analytics
Ibex Medical Analytics was founded by Joseph Mossel and Dr. Chaim Linhart. Ibex provides the first-ever AI-based cancer diagnosis solution in routine clinical use in pathology labs, supporting pathologists in delivering accurate, rapid and objective diagnosis of prostate biopsies. Ibex’ product is deployed across the laboratory’s workflow and builds on deep learning algorithms developed by a team of data scientists, software engineers and pathologists. The company has recently raised $11 million from prominent VC funds and corporate investors.
For more information: www.ibex-ai.com
About Medipath
Medipath is France’s largest network of pathology laboratories, owned exclusively by 68 pathologists. Medipath fulfills a public health mission in cancer diagnosis. Its team has 270 employees, 5 expert pathologists in rare diseases and 6 molecular pathologists. It collaborates with 84 clinics and 39 hospitals across France (such as the prestigious American Hospital of Paris) and deals with 800,000 cases every year, including 60,000 cancer diagnoses. As a pioneer in the quality process (5 accreditation scopes), Medipath takes part in independent quality checks, recognized nationwide (AFAQAP) and worldwide (UK NEQAS, QCMD). In 2018, the group’s turnover reached €43 million.
For more information: https://www.medipath.fr/
Ibex Medical Analytics media contact :
Tsipi Joseph
G2M TEAM
tsipi@g2mteam.com
Medipath media contact :
Sophie Facq
Responsible of communication
s.facq@medipath.fr
